Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma

Authors

Institutions

Publication Details

Journal
Haematologica
Published
2026-07-02
DOI
https://doi.org/10.3324/haematol.2026.300899
Primary Topic
Phagocytosis and Immune Regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma

Michael A. Spinner, R Advani, Reid Merryman, Margaret Shipp et al.
Haematologica
Phagocytosis and Immune Regulation
article

Anti-CD47 antibody magrolimab with pembrolizumab in patients with relapsed / refractory classic Hodgkin lymphoma

Michael A. Spinner, R Advani, Reid Merryman, Margaret Shipp, Cheryl Chang, Austin Yeung, Chandley Silin, Joseph G. Schroers-Martin, Philippe Armand, May Powell
article en

Abstract

No abstract available for this paper.
Haematologica
Duke University (US), University of California, San Francisco (US), Dana-Farber Cancer Institute (US), Stanford Medicine (US), Stanford University (US)
Good health and well-being
Openalex Percentile: Top 12%
Phagocytosis and Immune Regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.